跳至主要内容
临床试验/IRCT2014062518232N1
IRCT2014062518232N1已完成未知

The effect of salbutamol in treatment of transient tachypnea of newborn

Vice chancellor for research, Babol University of Medical Sciences0 个研究点目标入组 70 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
70

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
1 day 至 1 day(—)
性别
All

入选标准

  • Inclusion criteria:
  • The late preterm (gestational age of 34 – 37 weeks) and term (gestational ageof 37 -42 weeks) and post term (gestational age greater than 42 weeks) neonates with tachypnea (Respiratory Rate greater than 60 per minute) with or without respiratory distress within 6 hours of birth.
  • Exclusion criteria:
  • Pretem neonates (gestational age less than 34 weeks); neonates with history of asphyxia; birth trauma; meconium aspiration syndrome; congenital pneumonia; a history of chorioamnionitis or corticosteroids therapy in mother; gross congenital anomaly and neonates with tachycardia; arythmia; blood culture or CRP positive during treatment will be excluded.

排除标准

  • 未提供

研究者

发起方
Vice chancellor for research, Babol University of Medical Sciences

相似试验